• Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease

    Xconomy | Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. New biotech Goldfinch Bio wants to turn genetic research into new therapies.

    Dec 14, 2016

  • New Funds for ONT, Self-Sequencing Challenge from Clive Brown

    Bio-IT World Oxford Nanopore Technologies yesterday announced $126 million in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare, a pan-Asian fund with special reach in China, and existing investor Woodford Investment Management on behalf of its clients. Clive Brown, Oxford Nanopore's CTO, also released the "Cliveome" yesterday, his own self-sequenced genome.

    Dec 13, 2016

  • Complexities Of Consent

    Clinical Informatics News | As genomics continues to grow and evolve, the need to find a balance between scientific progress and patient protection is as great as ever.

    Dec 13, 2016

  • CRISPR Tech Heralds Hype, Hope, and Hurdles for Gene-Based Therapeutics

    Bio-IT World | The age of CRISPR has heralded in new lines of business based on cutting-edge, gene-editing technologies. Here are a few of the highlights of CRISPR's impact on the industry.

    Dec 12, 2016

  • First US Exascale Supercomputer Now On Track for 2021

    Top500 | The US Department of Energy's Exascale Computing Project (ECP) has changed its timeline for getting the first post-petascale system into the field. The new goal is to get an initial exascale system deployed sometime in 2021, with acceptance nine months after that. That shrinks the schedule significantly and puts the country back on a more competitive trajectory with regard to China and Japan.

    Dec 12, 2016

  • DNAnexus Reanalyzes Cancer Genome Atlas Data

    Bio-IT World Brief | DNAnexus announced today that it has performed uniform reanalysis and mutation calling on the world’s largest pan-cancer dataset, encompassing 10,487 patients across 33 cancer types from The Cancer Genome Atlas (TCGA). The mutation data has undergone additional quality control and filtering and is available as an open access dataset for download at the NCI Genomic Data Commons and on Synapse. The pipelines used are also fully available to researchers who wish to reproduce this TCGA mutation discovery via DNAnexus or a GitHub repository.

    Dec 9, 2016

  • Francis Collins says he would remain NIH director under Trump

    STAT | The director of the NIH said Friday that it would be a "privilege" to remain in that post if asked to stay by President-elect Donald Trump.

    Dec 9, 2016

  • Controversial Impact Factor Gets a Heavyweight Rival

    Nature News & Comment | On December 8, Elsevier launched the CiteScore Index, a new way to assess the quality of academic journals. Elsevier's CiteScore uses a larger database - and provides different results than the Journal Impact Factor.

    Dec 8, 2016